PROCEPT BioRobotics (PRCT) Net Cash Flow (2020 - 2026)
PROCEPT BioRobotics (PRCT) reported Net Cash Flow of -$40.8 million for Q1 2026, down 133.01% year-over-year from $123.6 million in Q1 2025, and down 427.58% on a QoQ basis from -$7.7 million in Q4 2025.
PROCEPT BioRobotics (PRCT) has 7 years of Net Cash Flow data on file, last reported at -$40.8 million in Q1 2026.
- Quarterly Net Cash Flow fell 133.01% year-over-year to -$40.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$70.4 million (down 177.73% YoY) and the FY2025 annual result came in at -$47.1 million, down 161.63% from the prior year.
- Net Cash Flow declined to -$40.8 million in Q1 2026 per PRCT's latest filing, from -$7.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $137.4 million in Q3 2023 and bottomed at -$40.9 million in Q1 2023.
- The 5-year median for Net Cash Flow is -$17.3 million (2024), against an average of -$3.3 million.
- Peak annual rise in Net Cash Flow reached 767.36% in 2023, while the deepest fall reached 140.58% in 2023.
- Tracing PRCT's Net Cash Flow over 5 years: stood at -$27.4 million in 2022, then fell by 12.0% to -$30.6 million in 2023, then soared by 546.98% to $137.0 million in 2024, then sank by 105.65% to -$7.7 million in 2025, then slumped by 427.58% to -$40.8 million in 2026.
- Per Business Quant, the three latest PRCT Net Cash Flow figures stand at -$40.8 million (Q1 2026), -$7.7 million (Q4 2025), and -$8.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.30 Mn |
| 10 | PROCEPT BioRobotics | 1.58 Bn | 1.33 Bn | 53.95 Mn | -40.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.82 Mn |
| Mar 31, 2026 | -40.82 Mn |
| Dec 31, 2025 | -7.74 Mn |
| Dec 31, 2025 | -7.74 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Jun 30, 2025 | -13.47 Mn |
| Jun 30, 2025 | -13.47 Mn |
| Mar 31, 2025 | -17.52 Mn |
| Mar 31, 2025 | -17.52 Mn |
| Dec 31, 2024 | 136.96 Mn |
| Dec 31, 2024 | 136.96 Mn |
| Sep 30, 2024 | -17.33 Mn |
| Sep 30, 2024 | -17.33 Mn |
| Jun 30, 2024 | -11.48 Mn |
| Jun 30, 2024 | -11.48 Mn |
| Mar 31, 2024 | -31.65 Mn |
| Mar 31, 2024 | -31.65 Mn |
| Dec 31, 2023 | -30.64 Mn |
| Dec 31, 2023 | -30.64 Mn |
| Sep 30, 2023 | 137.40 Mn |
| Sep 30, 2023 | 137.40 Mn |
| Jun 30, 2023 | -31.28 Mn |
| Jun 30, 2023 | -31.28 Mn |
| Mar 31, 2023 | -40.89 Mn |
| Mar 31, 2023 | -40.89 Mn |
| Dec 31, 2022 | -27.36 Mn |
| Dec 31, 2022 | -27.36 Mn |
| Sep 30, 2022 | -20.59 Mn |
| Sep 30, 2022 | -20.59 Mn |
| Jun 30, 2022 | -14.48 Mn |
| Jun 30, 2022 | -14.48 Mn |
| Mar 31, 2022 | -17.00 Mn |
| Mar 31, 2022 | -17.00 Mn |
| Dec 31, 2021 | -16.16 Mn |
| Dec 31, 2021 | -16.16 Mn |
| Sep 30, 2021 | 161.26 Mn |
| Sep 30, 2021 | 161.26 Mn |
| Jun 30, 2021 | 73.11 Mn |
| Jun 30, 2021 | 73.11 Mn |
| Mar 31, 2021 | -14.01 Mn |
| Mar 31, 2021 | -14.01 Mn |
| Dec 31, 2020 | -13.22 Mn |
| Dec 31, 2020 | -13.22 Mn |